A 6-month prospective trial of a personalized behavioral intervention + long-acting injectable antipsychotic in individuals with schizophrenia at risk for treatment non-adherence and homelessness

PURPOSE: Long-acting injectable antipsychotic medication (LAI) can optimize adherence for high-risk serious mental illness (SMI). This Customized Adherence Enhancement approach delivered by social worker interventionists was combined with LAI (CAE-L) of paliperidone palmitate for homeless, poorly-ad...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Psychopharmacol
Main Authors: Sajatovic, Martha, Ramirez, Luis F., Fuentes-Casiano, Edna, Cage, Jamie, Tatsuoka, Curtis, Aebi, Michelle E., Bukach, Ashley, Cassidy, Kristin A., Levin, Jennifer B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5678972/
https://ncbi.nlm.nih.gov/pubmed/28930768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000778
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados